Zacks Research Has Pessimistic Outlook of RLI Q2 Earnings

RLI Corp. (NYSE:RLIFree Report) – Research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for RLI in a report released on Wednesday, March 18th. Zacks Research analyst Team now forecasts that the insurance provider will earn $0.68 per share for the quarter, down from their previous estimate of $0.74. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for RLI’s current full-year earnings is $3.08 per share. Zacks Research also issued estimates for RLI’s FY2026 earnings at $2.72 EPS, Q1 2027 earnings at $0.80 EPS, Q2 2027 earnings at $0.67 EPS and Q3 2027 earnings at $0.62 EPS.

A number of other brokerages also recently weighed in on RLI. Keefe, Bruyette & Woods upgraded shares of RLI from a “moderate buy” rating to a “strong-buy” rating in a report on Tuesday, February 24th. Citizens Jmp reiterated a “market perform” rating on shares of RLI in a research note on Friday, January 23rd. Truist Financial set a $58.00 price objective on shares of RLI in a research report on Friday, January 23rd. Jefferies Financial Group raised shares of RLI from an “underperform” rating to a “hold” rating and set a $52.00 target price on the stock in a report on Friday, January 23rd. Finally, Wells Fargo & Company set a $59.00 target price on shares of RLI and gave the company an “equal weight” rating in a research note on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, RLI currently has a consensus rating of “Hold” and an average target price of $65.20.

View Our Latest Stock Report on RLI

RLI Trading Down 0.1%

NYSE RLI opened at $58.03 on Friday. The company has a market cap of $5.33 billion, a PE ratio of 13.31 and a beta of 0.50. RLI has a 12 month low of $55.80 and a 12 month high of $81.79. The stock has a 50 day moving average of $60.34 and a 200-day moving average of $62.37.

RLI (NYSE:RLIGet Free Report) last posted its quarterly earnings results on Wednesday, January 21st. The insurance provider reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.76 by $0.18. The firm had revenue of $465.69 million during the quarter, compared to the consensus estimate of $447.53 million. RLI had a return on equity of 18.67% and a net margin of 21.43%.During the same period last year, the company earned $0.41 earnings per share.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of RLI. Wasatch Advisors LP acquired a new stake in RLI during the second quarter worth about $84,608,000. Norges Bank acquired a new position in shares of RLI in the 4th quarter valued at approximately $66,997,000. Victory Capital Management Inc. lifted its holdings in shares of RLI by 6,060.1% during the 4th quarter. Victory Capital Management Inc. now owns 739,709 shares of the insurance provider’s stock worth $47,327,000 after acquiring an additional 727,701 shares during the period. Bank of Montreal Can lifted its holdings in shares of RLI by 3,664.4% during the 4th quarter. Bank of Montreal Can now owns 368,384 shares of the insurance provider’s stock worth $23,569,000 after acquiring an additional 358,598 shares during the period. Finally, Two Sigma Investments LP boosted its position in shares of RLI by 353.1% during the 3rd quarter. Two Sigma Investments LP now owns 446,378 shares of the insurance provider’s stock worth $29,113,000 after acquiring an additional 347,858 shares in the last quarter. Institutional investors and hedge funds own 77.89% of the company’s stock.

Insiders Place Their Bets

In related news, COO Jennifer L. Klobnak bought 2,000 shares of RLI stock in a transaction dated Friday, January 23rd. The shares were bought at an average cost of $57.99 per share, with a total value of $115,980.00. Following the acquisition, the chief operating officer owned 100,318 shares in the company, valued at $5,817,440.82. This trade represents a 2.03% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Craig W. Kliethermes bought 5,000 shares of RLI stock in a transaction dated Friday, January 23rd. The shares were bought at an average cost of $57.45 per share, for a total transaction of $287,250.00. Following the completion of the acquisition, the chief executive officer owned 143,990 shares in the company, valued at $8,272,225.50. This represents a 3.60% increase in their position. The SEC filing for this purchase provides additional information. 2.16% of the stock is owned by company insiders.

RLI Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date was Monday, March 2nd. RLI’s dividend payout ratio (DPR) is 14.68%.

About RLI

(Get Free Report)

RLI Corporation (NYSE:RLI) is a specialty property and casualty insurance company focused on underwriting niche risks for businesses and individuals. Headquartered in Peoria, Illinois, the company operates through a network of independent agents and brokers, offering customized coverage solutions. RLI’s approach emphasizes disciplined underwriting, targeted product development and strong customer service to maintain profitability and long-term growth.

Founded in 1965 as Replacement Lens, Inc, RLI initially provided insurance for contact lens manufacturers before shifting its focus to specialty insurance in the 1980s.

Recommended Stories

Earnings History and Estimates for RLI (NYSE:RLI)

Receive News & Ratings for RLI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RLI and related companies with MarketBeat.com's FREE daily email newsletter.